Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, March 28, 2017

Public edition |

Newswise Cancer Research Wire for 28-Mar-2017

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Rogue Breast Tumor Proteins Point to Potential Drug Therapies

For patients with difficult-to-treat cancers, doctors increasingly rely on genomic testing of tumors to identify errors in the DNA that indicate a tumor can be targeted by existing therapies. But this approach overlooks rogue proteins that may be dri...

– Washington University in St. Louis

Nature Communications

Embargo expired on 28-Mar-2017 at 05:00 ET

New Study Suggests That Vitamin D Decreases Risk of Cancer

Evidence suggests that low vitamin D status may increase the risk of cancer.

– Creighton University

The Journal of the American Medical Association

embargoed until 28-Mar-2017, 11:00 ET

ENDO 2017 News Conferences to Feature Obesity/Diabetes Technologies, Endocrine-Disrupting Chemicals, Thyroid and Men’s Health Research

News conferences will explore the latest research advances in obesity and diabetes technologies, thyroid conditions, men’s health and endocrine-disrupting chemicals at ENDO 2017, the Endocrine Society’s 99th Annual Meeting & Expo. The meeting wil...

– Endocrine Society

ENDO 2017, Apr-2017

Study Provides Path for New Immunotherapy Approaches to Prostate Cancer

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderso...

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 27-Mar-2017 at 11:00 ET

How Randomness Helps Cancer Cells Thrive

In a research effort that merged genetics, physics and information theory, a team at the Schools of Medicine and Engineering at Johns Hopkins University has added significantly to evidence that large regions of the human genome have built-in variabil...

– Johns Hopkins Medicine

R01CA054358, DP1ES022579, AG021334, CCF-1217213.CCF-1656201

Embargo expired on 27-Mar-2017 at 11:00 ET

Minority Colorectal Cancer Patients Report Higher Burden of Poor Quality-of-Life Than Whites

A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) than white patients and that ...

– University of Texas M. D. Anderson Cancer Center

American Association for Cancer Research Annual Meeting

UT Southwestern First in Texas to Premiere Latest Gamma Knife Icon Technology

Patsy Whittenberg made the six-hour drive from the Texas Panhandle to UT Southwestern Medical Center in Dallas to take advantage of a first for Texas –the latest in Gamma Knife surgery ­that better protects surrounding brain tissue and offers gre...

– UT Southwestern Medical Center

Researchers Warn of Hazards of Smoking and Need for Wider Use of Varenicline to Quit

More than 35 million Americans are trying to quit smoking. Experts reassure clinicians and their patients that varenicline, whose brand name is Chantix, is a safe and effective way to achieve smoking cessation and that failure to use this drug has ca...

– Florida Atlantic University

American Journal of Medicine

From the Room Next Door to the Next Planet Over

The new Albert Chadwick Research Room inside the Roberts Proton Therapy Center is no ordinary laboratory space. In fact, there’s nothing else quite like it anywhere else in the United States, and whether it’s treating patients with cancer or help...

– Perelman School of Medicine at the University of Pennsylvania

Drug Trial for Solid Cancer Tumors, Lynch Syndrome Awareness, Side Effects for Prostate Cancer Treatments, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

– Newswise

Nanoparticle Paves the Way for New Triple Negative Breast Cancer Drug

A potential new drug to tackle the highly aggressive ‘triple negative’ breast cancer – and a nanoparticle to deliver it directly into the cancer cells – has been developed by UK researchers.

– Queen's University Belfast


Major Grant Accelerates Cancer Research

A $9.5 million, five-year grant from the National Cancer Institute (NCI) will fund an intensive multidisciplinary research effort that seeks to better understand how cancer cells reach an aggressive state and begin to damage surrounding tissue.

– Yale Cancer Center

Colon Cancer: Early Detection Can Save Your Life

Colorectal cancer is the second leading cause of cancer death for men and women in the United States according to the American Cancer Society (ACS). In fact, the ACS estimates that 134,490 people in the United States were diagnosed with colorectal ca...

– Valley Health System

Immunotherapy Drug Becomes First Therapy Approved by FDA for Rare Skin Cancer

The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma. Dr. Paul Nghiem, a senior investigator on the clinical t...

– Fred Hutchinson Cancer Research Center

Colorectal Cancer Rates Up Among Young Adults; What You Should Know

Researchers predict that 13,500 new cases of colon and rectal cancers will be diagnosed in Americans under age 50 this year; in all age groups, about 100,000 cases of colon cancer and nearly 40,000 cases of rectal cancer are expected.

Expert Available

– University of California, Los Angeles (UCLA), Health Sciences

Preterm Births More Common in Mothers Who Are Cancer Survivors

In a study published in the journal JAMA Oncology, UNC Lineberger Comprehensive Cancer Center researchers report that women diagnosed and treated for cancer during their childbearing years more commonly gave birth prematurely, and to babies whose wei...

– University of North Carolina Health Care System

JAMA Oncology, March-2017

Embargo expired on 23-Mar-2017 at 11:00 ET

A New Approach to Diagnosing Mental Disorders Could Become an Alternative to DSM-5

A consortium of psychiatrists and psychologists from universities worldwide, co-led by Stony Brook University, University of Minnesota and University of Notre Dame, has proposed a new approach to diagnosing mental disorders.

– Stony Brook University

Journal of Abnormal Psychology

Embargo expired on 23-Mar-2017 at 09:00 ET

Team of Scientists Demonstrate Path for Tackling Rare Cancers with No Effective Treatment

Study results indicate importance of treatment based on genetic mutation rather than location of origin

– Mount Sinai Health System

UVA Discovers ANOTHER Immune System Link Science Said Didn't Exist

UVA researchers have again shown that a part of the body thought to be disconnected from the immune system actually interacts with it, and that discovery helps explain cases of male infertility, certain autoimmune diseases and even the failure of can...

– University of Virginia Health System

Journal of Clinical Investigation; R01AI41236

Statins May Provide Treatment Alternative for Chronic Liver Disease

Statin drugs are widely used to manage high cholesterol and reduce the risk of cardiovascular disease. But in a new review of more than 50 studies, researchers cite reductions in liver inflammation and improvements in other related factors as reasons...

– American Physiological Society (APS)

Virtual Environment Education Reduces Anxiety Prior to Radiation Therapy in Prostate Cancer Patients

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and the Sidn...

– Thomas Jefferson University

Journal of Radiation Oncology, March 2017

Researchers Identify First Evidence of Epigenetic Role in Breast Cancer

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer. The team found that inhibition of the PI3K pathway leads to activation of ER-dependent transcription t...

– Memorial Sloan Kettering Cancer Center


Hitting Cancer with High-Intensity Ultrasound and Immunotherapy

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse mode...

– UC Davis Comprehensive Cancer Center

‘First in Human’ Trial Defines Safe Dosage for Small Molecule Drug ONC201 for Solid Cancer Tumors

A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients with advanced solid tumors shows that this investigational drug is well tolerated at the recommended phase II dose. That’s according to Rutgers Cancer...

– Rutgers Cancer Institute of New Jersey

Clinical Cancer Research, Mar-2017

AMP Issues Best Practice Guidelines for Next-Generation Sequencing-Based Oncology Panel Validation

AMP has published consensus recommendations that will help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients

– Association for Molecular Pathology

New Colon Cancer Biomarkers May Guide Development of Personalized Treatment

Researchers at Baylor Scott & White Research Institute identified a new genetic biomarker for colon cancer that may lead to development of more targeted treatment of the disease

– Baylor Scott and White Health

Clinical Cancer Research, February 7, 2017

Researchers Review Emerging Role of MicroRNAs in Liquid Biopsies for GI Cancers

A review article in <i>Clinical Cancer Research</i> by Investigators from Baylor Scott & White Research Institute examines the potential for microRNAs – molecules that regulate gene expression – to detect gastrointestinal cancer in blood and othe...

– Baylor Scott and White Health


Public-Private Research Effort to Develop More Accurate Ways of Measuring Cancer Progression

Columbia and NewYork-Presbyterian to participate in program led by the Foundation for the National Institutes of Health Biomarkers Consortium

– Columbia University Medical Center

NIH Grant Will Further Investigation of Breast Tumor Margin Assessment

The National Institutes of Health has awarded a three-year, $424,081 grant to Magda El-Shenawee, electrical engineering professor, for her work on an intraoperative and rapid method of detecting positive cancer margins during conservative breast canc...

– University of Arkansas, Fayetteville

NCCN Foundation Board Names New Leadership

Gena Cook, Co-Founder and Chief Executive Officer, Navigating Cancer, and Heather Kopecky, PhD, MBA, Senior Client Partner, Korn Ferry, have been named Chair and Vice-Chair, respectively, of the NCCN Foundation Board of Directors.

– National Comprehensive Cancer Network® (NCCN®)

New NCCN Radiation Therapy Compendium™ Aids in Decision-Making for Patients with Cancer

Launched during the NCCN 22nd Annual Conference, the new NCCN Radiation Therapy Compendium™ provides a single access point for radiation therapy recommendations within the NCCN Guidelines®.

– National Comprehensive Cancer Network® (NCCN®)

Keck School of Medicine of USC Receives Grant to Fund Research on the Link Between Gastroesophageal Reflux Disease and Esophageal Cancer

The Keck School of Medicine of the University of Southern California (USC) has received a grant to fund research on the link between gastroesophageal reflux disease and esophageal cancer.

– Keck Medicine of USC

MedStar Washington Hospital Center Receives $232,000 to Combat Crisis of Advanced Colon Cancer Among African-Americans in Ward 5

The American Cancer Society and the Cigna Foundation have awarded $232,000 in grants to MedStar Washington Hospital Center to support its innovative community-based program to address the crisis of advanced colon cancer, occurring largely among Afric...

– MedStar Washington Hospital Center

Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins Cytosorbents Scientific Advisory Board

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced...

– CytoSorbents Corporation

Dana-Farber Cancer Institute, Lifespan Sign Long-Term Agreement to Advance Cancer Treatment and Research

Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research.

– Dana-Farber Cancer Institute

Expert Pitch

Gynecologic Cancers Expert at NewYork-Presbyterian Available to Discuss the Safety and Effectiveness of Laparoscopic Hysterectomies for Early Stage Endometrial Cancer Based on a New Study in JAMA of the LACE Trial

– New York-Presbyterian Hospital

embargoed until 28-Mar-2017, 11:00 ET

FDA Reports Deaths Linked to Breast Implants, Speak with Dr. Williams Gradishar to Learn About Anaplastic Large Cell Lymphoma (BIA-ALCL)

– Northwestern Medicine





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:


 Stony Brook University

 University of Virginia Health System

 American Physiological Society (APS)

 Queen's University Belfast

 University of California, Los Angeles (UCLA), Health Sciences

 University of Texas M. D. Anderson Cancer Center

 Washington University in St. Louis

 UT Southwestern Medical Center

 Northwestern Medicine

 Columbia University Medical Center

 University of Arkansas, Fayetteville

Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us